{"preliminary_commentary":{"by_channel":{"x_thread":10,"podcast":5,"youtube":2},"note":"Preliminary. Indexed podcasts, YouTube videos and X posts that name this trial so far. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this."},"free_build":{"available":true,"how":"POST https://www.erudio.com/api/trial-requests with {\"nct_id\": \"NCT01611766\", \"email\": \"<work email>\"}. The person who owns that inbox must confirm by the emailed link; agents cannot confirm. The result is the report's free public preview; the full report is still bought."},"commentary_summary":null,"drugs_tested":[],"indication":"platinum-sensitive relapsed ovarian cancer","name":"SOC-1","nct_id":"NCT01611766","offer":{"currency":"USD","how":"Order at https://www.erudio.com/contact?report=soc-1-nct01611766. The price is an estimate of verified statements from the commentary indexed so far. Final coverage is set when the report is built. You never pay more than quoted: if the report is delivered at a smaller size, you pay that size's price, and anything paid above it is refunded. We build the report within 24 hours of confirming the order and deliver it when it passes our checks; if it cannot be built to our standard, nothing is charged.","price_rule":"Never more than quoted: the buyer pays the smaller of price_usd and the price the delivered edition is sold at.","price_usd":1250,"size":"standard","size_rule":"Standard: 151–300 verified statements, estimated at 14 per indexed commentary source"},"registry":{"acronym":null,"arms":[{"description":"SCR followed by chemotherapy","label":"secondary cytoreductive surgery","type":"EXPERIMENTAL"},{"description":"platinum-based chemotherapy","label":"Salvage Chemotherapy","type":"ACTIVE_COMPARATOR"}],"collaborators":["Fudan University","Zhejiang Cancer Hospital","Shanghai Zhongshan Hospital","Sun Yat-sen University"],"completion_date":{"date":"2022-12","type":"ESTIMATED"},"conditions":["Ovarian Epithelial Cancer Recurrent","Fallopian Tube Carcinoma","Primary Peritoneal Carcinoma"],"enrollment":{"count":356,"type":"ESTIMATED"},"has_results":false,"interventions":[{"name":"Secondary Cytoreductive Surgery","otherNames":["Maximum effort cytoreductive surgery"],"type":"PROCEDURE"},{"name":"Salvage Chemotherapy","otherNames":["second line chemotherapy"],"type":"DRUG"}],"last_update":"2021-06-10","lead_sponsor":"Shanghai Gynecologic Oncology Group","official_title":"Evaluation of Secondary Cytoreductive Surgery in Platinum-Sensitive Recurrent Ovarian Cancer: A Phase III, Multicenter, Randomized Trial","overall_status":"UNKNOWN","phases":["PHASE3"],"primary_completion_date":{"date":"2019-12","type":"ACTUAL"},"primary_outcomes":[{"measure":"Overall survival","timeFrame":"Up to 60 months after last patient randomized"},{"measure":"Progression-free survival","timeFrame":"Up to 24 months after last patient randomized"}],"references":[{"citation":"Jiang R, Feng Y, Chen Y, Cheng X, Shi T, Gao W, Jia H, Jiang S, Guo Y, Huang X, Tu D, Zhang Y, Yang H, Zhang P, Liu J, Zhu J, Zang R; SOC-1 Investigators. Surgery versus no surgery in platinum-sensitive relapsed ovarian cancer: final overall survival analysis of the SOC-1 randomized phase 3 trial. Nat Med. 2024 Aug;30(8):2181-2188. doi: 10.1038/s41591-024-02981-0. Epub 2024 Jun 1.","pmid":"38824243","type":"DERIVED"},{"citation":"Shi T, Zhu J, Feng Y, Tu D, Zhang Y, Zhang P, Jia H, Huang X, Cai Y, Yin S, Jiang R, Tian W, Gao W, Liu J, Yang H, Cheng X, Zang R. Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial. Lancet Oncol. 2021 Apr;22(4):439-449. doi: 10.1016/S1470-2045(21)00006-1. Epub 2021 Mar 8.","pmid":"33705695","type":"DERIVED"}],"start_date":{"date":"2012-07-19","type":"ACTUAL"},"study_type":"INTERVENTIONAL","title":"Surgery or Chemotherapy in Recurrent Ovarian Cancer (SOC 1 Trial)?","url":"https://clinicaltrials.gov/study/NCT01611766"},"report":null,"schema_id":"erudio.trial_listing","schema_version":"3.2","state":"listed","state_text":"No report yet. It can be ordered.","url":"https://www.erudio.com/trials/soc-1-nct01611766"}